litlas
ログインアカウント作成

Edo Vellenga

1982–2024 年に発表

145
論文数
21,355
被引用数
95
h 指数
145
i10 指数

被引用数

Edo Vellenga の年別被引用数1943 年: 被引用 1 件1982 年: 被引用 2 件1983 年: 被引用 2 件1984 年: 被引用 3 件1985 年: 被引用 2 件1986 年: 被引用 4 件1987 年: 被引用 7 件1988 年: 被引用 16 件1989 年: 被引用 42 件1990 年: 被引用 33 件1991 年: 被引用 24 件1992 年: 被引用 25 件1993 年: 被引用 25 件1994 年: 被引用 15 件1995 年: 被引用 20 件1996 年: 被引用 14 件1997 年: 被引用 19 件1998 年: 被引用 29 件1999 年: 被引用 29 件2000 年: 被引用 58 件2001 年: 被引用 74 件2002 年: 被引用 77 件2003 年: 被引用 109 件2004 年: 被引用 89 件2005 年: 被引用 131 件2006 年: 被引用 143 件2007 年: 被引用 130 件2008 年: 被引用 149 件2009 年: 被引用 142 件2010 年: 被引用 165 件2011 年: 被引用 206 件2012 年: 被引用 193 件2013 年: 被引用 176 件2014 年: 被引用 164 件2015 年: 被引用 186 件2016 年: 被引用 162 件2017 年: 被引用 160 件2018 年: 被引用 161 件2019 年: 被引用 581 件2020 年: 被引用 540 件2021 年: 被引用 615 件2022 年: 被引用 367 件2023 年: 被引用 267 件2024 年: 被引用 412 件2025 年: 被引用 157 件2026 年: 被引用 1 件1944〜1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,265 件、この内訳の 24.8%ドイツ: 引用元論文 700 件、この内訳の 7.7%イギリス: 引用元論文 654 件、この内訳の 7.2%オランダ: 引用元論文 605 件、この内訳の 6.6%中国: 引用元論文 558 件、この内訳の 6.1%イタリア: 引用元論文 518 件、この内訳の 5.7%フランス: 引用元論文 441 件、この内訳の 4.8%カナダ: 引用元論文 321 件、この内訳の 3.5%スペイン: 引用元論文 296 件、この内訳の 3.2%オーストラリア: 引用元論文 254 件、この内訳の 2.8%日本: 引用元論文 216 件、この内訳の 2.4%スイス: 引用元論文 189 件、この内訳の 2.1%
0%24.8%その他 23.1%

機関

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology24.5%
  • Immunology and Microbiology4.6%
  • Neuroscience0.9%
  • Agricultural and Biological Sciences0.4%
  • Computer Science0.3%
  • その他1.7%

トピック

  • Acute Myeloid Leukemia Research10.5%
  • Multiple Myeloma Research and Treatments3.9%
  • Hematopoietic Stem Cell Transplantation3.2%
  • Protein Degradation and Inhibitors2.7%
  • Epigenetics and DNA Methylation2.5%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.3%
  • その他74.9%

共著者

全論文

検索で開く
  1. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    著者: Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia‐Manero, Rena Buckstein, Valeria Santini, María Díez‐Campelo, Carlo Finelli, Mario Cazzola, Osman İlhan, Mikkael A. Sekeres, José Falantes, Beatriz Arrizabalaga, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, Dominik Selleslag, Amy E. DeZern, Joseph G. Jurcic, Ulrich Germing, Katharina S. Götze, Bruno Quesnel, Odile Beyne‐Rauzy, Thomas Cluzeau, Maria-Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L. Greenberg, Eva Hellström-Lindberg, Amer M. Zeidan, Lionel Adès, Amit Verma, Michael R. Savona, Abderrahmane Laadem, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Diana Dunshee, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, Alan F. List - New England Journal of Medicine 2020 被引用: 537

  2. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients

    著者: Niels Grote Beverborg, IJsbrand T. Klip, Wouter C. Meijers, Adriaan A. Voors, Eline L. Vegter, Haye H. van der Wal, Dorine W. Swinkels, Joost van Pelt, André B. Mulder, Sjoerd K. Bulstra, Edo Vellenga, Massimo A. Mariani, Rudolf A. de Boer, Dirk J. van Veldhuisen, Peter van der Meer - Circulation Heart Failure 2018 被引用: 268

  3. High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

    著者: Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten, Harry C. Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Johan Maertens, Mojca Jongen‐Lavrencic, Marie von Lilienfeld‐Toal, Bart J. Biemond, Edo Vellenga, Marinus van Marwijk Kooy, Leo F. Verdonck, Joachim Beck, Hartmut Döhner, Aloïs Gratwohl, Thomas Pabst, Gregor Verhoef - New England Journal of Medicine 2009 被引用: 822

  4. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

    著者: Pau Montesinos, Juan Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Ángel León, Jordi Esteve, Giuseppe Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Diaz‐Mediavilla, José D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Löwenberg, Miguel Á. Sanz - Blood 2008 被引用: 364

  5. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

    著者: Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes, Michele Baccarani, M B Agarwal, María Soledad Undurraga, Jianxiang Wang, Juan Julio Kassack Ipiña, Dong‐Wook Kim, Michinori Ogura, Carolina Pavlovsky, Christian Junghanß, Jorge Milone, Franck E. Nicolini, Tadeusz Robak, Jan Van Droogenbroeck, Edo Vellenga, M. Brigid Bradley‐Garelik, Chao Zhu, Andreas Hochhaus - Blood 2011 被引用: 605

  6. The multifaceted role of autophagy in cancer and the microenvironment

    著者: Hendrik Folkerts, Susan Hilgendorf, Edo Vellenga, Edwin Bremer, Valerie R. Wiersma - Medicinal Research Reviews 2018 被引用: 203

  7. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

    著者: Bob Löwenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griškevičius, Lidwine W. Tick, Mojca Jongen‐Lavrencic, Marinus van Marwijk Kooy, Marie-Christiane Vekemans, Walter J. F. M. van der Velden, Berna Beverloo, Lucienne Michaux, Carlos Graux, Dries Deeren, Okke de Weerdt, Joost W. J. van Esser, Mario Bargetzi, Saskia K. Klein, Alain Gadisseur, Peter E. Westerweel, Hendrik Veelken, Michael Gregor, Tobias Silzle, Daniëlle van Lammeren-Venema, Ine Moors, Dimitri Breems, Mels Hoogendoorn, Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan J. Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjørn Tore Gjertsen, Jeroen J. W. M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J.M. Valk, Catharina Van Elssen, Markus G. Manz, Yngvar Fløisand, Gert J. Ossenkoppele - Blood Advances 2021 被引用: 66

  8. Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis

    著者: Vincent van den Boom, Henny Maat, Marjan Geugien, Aida Rodríguez López, Ana M. Sotoca, Jennifer Jaques, Annet Z. Brouwers-Vos, Fabrizia Fusetti, Richard W.J. Groen, Huipin Yuan, Anton C. Martens, Hendrik G. Stunnenberg, Edo Vellenga, Joost H.A. Martens, Jan Jacob Schuringa - Cell Reports 2015 被引用: 151

  9. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

    著者: Annemiek Broyl, Dirk Hose, Henk M. Lokhorst, Yvonne de Knegt, Justine Peeters, Anna Jauch, Uta Bertsch, Arjan Buijs, Marian Stevens‐Kroef, H. Berna Beverloo, Edo Vellenga, Sonja Zweegman, Marie-Josée Kersten, Bronno van der Holt, Laila el Jarari, George Mulligan, Hartmut Goldschmidt, Mark van Duin, Pieter Sonneveld - Blood 2010 被引用: 338

  10. Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

    著者: David P. Steensma, Pierre Fenaux, Koen Van Eygen, Azra Raza, Valeria Santini, Ulrich Germing, Patricia Font, María Díez‐Campelo, Sylvain Thépot, Edo Vellenga, Mrinal M. Patnaik, Jun Ho Jang, Helen Varsos, Jacqueline Bussolari, Esther Rose, Laurie Sherman, Libo Sun, Ying Wan, Souria Dougherty, Fei Huang, Faye Feller, Aleksandra Rizo, Uwe Platzbecker - Journal of Clinical Oncology 2020 被引用: 125

  11. Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

    著者: Dimitri Breems, Wim L.J. van Putten, Peter C. Huijgens, Gert J. Ossenkoppele, Gregor Verhoef, Leo F. Verdonck, Edo Vellenga, Georgine E. de Greef, E Jacky, J. van der Lelie, Marc Boogaerts, Bob Löwenberg - Journal of Clinical Oncology 2005 被引用: 515

  12. Cytarabine Dose for Acute Myeloid Leukemia

    著者: Bob Löwenberg, Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Bart J. Biemond, Aloïs Gratwohl, Georgine E. de Greef, Leo F. Verdonck, M Schaafsma, Michael Gregor, Matthias Theobald, Urs Schanz, Johan Maertens, Gert J. Ossenkoppele - New England Journal of Medicine 2011 被引用: 407

  13. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

    著者: Hartmut Goldschmidt, H M Lokhorst, E K, Bronno van der Holt, Igor Wolfgang Blau, Sonja Zweegman, Katja Weisel, Edo Vellenga, Michael Pfreundschuh, Marie José Kersten, Christof Scheid, Sandra Croockewit, Reinier Raymakers, Dirk Hose, Anna Potamianou, A. Jauch, Jens Hillengaß, Marian Stevens‐Kroef, Marc‐Steffen Raab, Annemiek Broijl, H. Lindemann, Gerard M.J. Bos, Peter Brossart, Marinus van Marwijk Kooy, Paula F. Ypma, Ulrich Duehrsen, Ron Schaafsma, Uta Bertsch, Thomas Hielscher, L. e. Jarari, Hans Salwender, Pieter Sonneveld - Leukemia 2017 被引用: 201

  14. Down-Regulation of E-Cadherin in Human Bronchial Epithelial Cells Leads to Epidermal Growth Factor Receptor-Dependent Th2 Cell-Promoting Activity

    著者: Irene H. Heijink, P. Marcel Kies, Henk F. Kauffman, Dirkje S. Postma, Antoon J. M. van Oosterhout, Edo Vellenga - The Journal of Immunology 2007 被引用: 181

  15. Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients

    著者: Gerwin Huls, Dana Chiţu, Violaine Havelange, Mojca Jongen‐Lavrencic, Arjan A. van de Loosdrecht, Bart J. Biemond, Harm Sinnige, Beata Hodossy, Carlos Graux, Rien van Marwijk Kooy, Okke de Weerdt, Dimitri Breems, Saskia K. Klein, Jürgen Kuball, Dries Deeren, Wim Terpstra, Marie‐Christiane Vekemans, Gert J. Ossenkoppele, Edo Vellenga, Bob Löwenberg, the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) - Blood 2019 被引用: 176

  16. Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

    著者: Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Edo Vellenga, Annemiek Broyl, Igor Wolfgang Blau, Katja Weisel, Shulamiet Wittebol, Gerard M.J. Bos, Marian Stevens‐Kroef, Christof Scheid, Michael Pfreundschuh, Dirk Hose, Anna Jauch, Helgi van de Velde, Reinier Raymakers, M Schaafsma, Marie José Kersten, Marinus van Marwijk-Kooy, Ulrich Duehrsen, Walter Lindemann, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut Goldschmidt - Journal of Clinical Oncology 2012 被引用: 826

  17. The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis

    著者: Bauke de Boer, Sofia Sheveleva, Katja Apelt, Edo Vellenga, André B. Mulder, Gerwin Huls, Jan Jacob Schuringa - Haematologica 2020 被引用: 38

  18. Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones

    著者: Bauke de Boer, Janine Prick, Maurien Pruis, Peter Keane, Maria Rosaria Imperato, Jennifer Jaques, Annet Z. Brouwers-Vos, Shanna M. Hogeling, Carolien M. Woolthuis, Marije T. Nijk, Arjan Diepstra, Sebastian K. Wandinger, Matthias Versele, Ricardo M. Attar, Peter N. Cockerill, Gerwin Huls, Edo Vellenga, André B. Mulder, Constanze Bonifer, Jan Jacob Schuringa - Cancer Cell 2018 被引用: 106

  19. Protein quality control in the nucleolus safeguards recovery of epigenetic regulators after heat shock

    著者: Maria Azkanaz, Aida Rodríguez López, Bauke de Boer, Wouter Huiting, Pierre‐Olivier Angrand, Edo Vellenga, Harm H. Kampinga, Steven Bergink, Joost H.A. Martens, Jan Jacob Schuringa, Vincent van den Boom - eLife 2019 被引用: 75

  20. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia

    著者: Gary Klein, Edo Vellenga, Marco W. Fraaije, Willem A. Kamps, Eveline S.J.M. de Bont - Critical Reviews in Oncology/Hematology 2004 被引用: 343

  21. eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data

    著者: Charles E. Breeze, Dirk S. Paul, Jenny van Dongen, Lee M Butcher, John C. Ambrose, James E. Barrett, Robert Lowe, Vardhman K. Rakyan, Valentina Iotchkova, Mattia Frontini, Kate Downes, Willem H. Ouwehand, Jonathan Laperle, Pierre‐Étienne Jacques, Guillaume Bourque, Anke K. Bergmann, Reiner Siebert, Edo Vellenga, Sadia Saeed, Filomena Matarese, Joost H.A. Martens, Hendrik G. Stunnenberg, Andrew E. Teschendorff, Javier Herrero, Ewan Birney, Ian Dunham, Stephan Beck - Cell Reports 2016 被引用: 147

  22. Constitutive NF-κB activation in AML: Causes and treatment strategies

    著者: Matthieu Bosman, Jan Jacob Schuringa, Edo Vellenga - Critical Reviews in Oncology/Hematology 2015 被引用: 105

  23. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation

    著者: Gerbrig Berger, Eva van den Berg, Birgit Sikkema‐Raddatz, Kristin M. Abbott, Richard J. Sinke, Laura Bungener, André B. Mulder, Edo Vellenga - Leukemia 2016 被引用: 88

  24. Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy

    著者: Katharina Mattes, Edo Vellenga, Hein Schepers - Critical Reviews in Oncology/Hematology 2019 被引用: 60